tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) Inc. (WXIBF)
OTHER OTC:WXIBF
US Market

Wuxi Biologics (Cayman) (WXIBF) Stock Forecast & Price Target

Compare
129 Followers
See the Price Targets and Ratings of:

WXIBF Analyst Ratings

Strong Buy
9Ratings
Strong Buy
7 Buy
2 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Wuxi
Biologics (Cayman)
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WXIBF Stock 12 Month Forecast

Average Price Target

$4.07
▲(20.41%Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is $4.07 with a high forecast of $5.73 and a low forecast of $2.98. The average price target represents a 20.41% change from the last price of $3.38.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","3":"$3","6":"$6","1.5":"$1.5","4.5":"$4.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.73399,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.9816748,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.98</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.5,3,4.5,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3,3.210306923076923,3.420613846153846,3.6309207692307695,3.8412276923076925,4.0515346153846155,4.261841538461539,4.4721484615384615,4.682455384615385,4.892762307692308,5.103069230769231,5.313376153846154,5.523683076923078,{"y":5.73399,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3,3.082307692307692,3.164615384615385,3.246923076923077,3.329230769230769,3.411538461538462,3.493846153846154,3.5761538461538462,3.6584615384615384,3.740769230769231,3.8230769230769233,3.905384615384616,3.987692307692308,{"y":4.07,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3,2.998590369230769,2.9971807384615383,2.9957711076923075,2.994361476923077,2.9929518461538462,2.9915422153846154,2.9901325846153846,2.9887229538461537,2.987313323076923,2.9859036923076925,2.9844940615384616,2.983084430769231,{"y":2.9816748,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.85,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.63,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.49,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.1,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.99,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.27,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5.73Average Price Target$4.07Lowest Price Target$2.98
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on WXIBF
Yang HuangJ.P. Morgan
J.P. Morgan
$4.08$3.57
Buy
5.56%
Upside
Reiterated
05/06/25
Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$28 at JPMorganJPMorgan analyst Yang Huang lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$28.00 (from HK$32.00) while maintaining a Overweight rating.
Jefferies Analyst forecast on WXIBF
Cui CuiJefferies
Jefferies
$5.73
Buy
69.64%
Upside
Reiterated
03/31/25
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Jefferies
Citi
$3.82$4.46
Buy
31.95%
Upside
Reiterated
03/31/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$35 at CitiCiti analyst John Yung raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$35.00 (from HK$30.00) while maintaining a Buy rating.
CMB International Securities Analyst forecast on WXIBF
Jill WuCMB International Securities
CMB International Securities
$3.09$3.94
Buy
16.64%
Upside
Reiterated
03/27/25
WuXi Biologics: Strong Growth and Strategic Expansion Drive Buy Rating and Target Price Increase
CLSA
$3.31$3.67
Buy
8.57%
Upside
Reiterated
03/27/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$28.80 at CLSACLSA analyst Michael Luo raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$28.80 (from HK$26.00) while maintaining a Outperform (2) rating.
Goldman Sachs Analyst forecast on WXIBF
Ziyi ChenGoldman Sachs
Goldman Sachs
$2.65$2.98
Hold
-11.78%
Downside
Reiterated
03/27/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$23.40 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$23.40 (from HK$20.80) while maintaining a Neutral rating.
UOB Kay Hian Analyst forecast on WXIBF
Unknown AnalystUOB Kay Hian
Not Ranked
UOB Kay Hian
$4.46
Buy
31.95%
Upside
Reiterated
03/27/25
Nomura
$3.9$4.38
Buy
29.53%
Upside
Reiterated
03/26/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$34.36 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$34.36 (from HK$30.59) while maintaining a Buy rating.
Macquarie Analyst forecast on WXIBF
Tony RenMacquarie
Macquarie
$3.44
Hold
1.79%
Upside
Reiterated
03/26/25
Macquarie Reiterates Neutral Rating on Wuxi Biologics (2269:HK) (WXXWY)Macquarie analyst Tony Ren reiterated a Neutral rating and HK$27.00 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).
DBS
$3.06
Hold
-9.52%
Downside
Reiterated
02/24/25
Hold Rating for WuXi Biologics Amid Biosecure Act Risks and Regulatory Challenges
Morgan Stanley Analyst forecast on WXIBF
Sean Wu CFAMorgan Stanley
Morgan Stanley
$4.08
Buy
20.64%
Upside
Reiterated
08/30/24
Morgan Stanley Reiterates Overweight Rating on Wuxi Biologics (2269:HK) (WXXWY)Morgan Stanley analyst Sean Wu reiterated an Overweight rating and HK$32.00 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).
UBS
$2.12
Hold
-37.42%
Downside
Reiterated
06/12/24
UBS Reiterates Neutral Rating on Wuxi Biologics (2269:HK) (WXXWY)UBS analyst Chen Chen reiterated a Neutral rating and HK$16.60 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on WXIBF
Yang HuangJ.P. Morgan
J.P. Morgan
$4.08$3.57
Buy
5.56%
Upside
Reiterated
05/06/25
Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$28 at JPMorganJPMorgan analyst Yang Huang lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$28.00 (from HK$32.00) while maintaining a Overweight rating.
Jefferies Analyst forecast on WXIBF
Cui CuiJefferies
Jefferies
$5.73
Buy
69.64%
Upside
Reiterated
03/31/25
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Jefferies
Citi
$3.82$4.46
Buy
31.95%
Upside
Reiterated
03/31/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$35 at CitiCiti analyst John Yung raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$35.00 (from HK$30.00) while maintaining a Buy rating.
CMB International Securities Analyst forecast on WXIBF
Jill WuCMB International Securities
CMB International Securities
$3.09$3.94
Buy
16.64%
Upside
Reiterated
03/27/25
WuXi Biologics: Strong Growth and Strategic Expansion Drive Buy Rating and Target Price Increase
CLSA
$3.31$3.67
Buy
8.57%
Upside
Reiterated
03/27/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$28.80 at CLSACLSA analyst Michael Luo raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$28.80 (from HK$26.00) while maintaining a Outperform (2) rating.
Goldman Sachs Analyst forecast on WXIBF
Ziyi ChenGoldman Sachs
Goldman Sachs
$2.65$2.98
Hold
-11.78%
Downside
Reiterated
03/27/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$23.40 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$23.40 (from HK$20.80) while maintaining a Neutral rating.
UOB Kay Hian Analyst forecast on WXIBF
Unknown AnalystUOB Kay Hian
Not Ranked
UOB Kay Hian
$4.46
Buy
31.95%
Upside
Reiterated
03/27/25
Nomura
$3.9$4.38
Buy
29.53%
Upside
Reiterated
03/26/25
Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$34.36 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang raised the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$34.36 (from HK$30.59) while maintaining a Buy rating.
Macquarie Analyst forecast on WXIBF
Tony RenMacquarie
Macquarie
$3.44
Hold
1.79%
Upside
Reiterated
03/26/25
Macquarie Reiterates Neutral Rating on Wuxi Biologics (2269:HK) (WXXWY)Macquarie analyst Tony Ren reiterated a Neutral rating and HK$27.00 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).
DBS
$3.06
Hold
-9.52%
Downside
Reiterated
02/24/25
Hold Rating for WuXi Biologics Amid Biosecure Act Risks and Regulatory Challenges
Morgan Stanley Analyst forecast on WXIBF
Sean Wu CFAMorgan Stanley
Morgan Stanley
$4.08
Buy
20.64%
Upside
Reiterated
08/30/24
Morgan Stanley Reiterates Overweight Rating on Wuxi Biologics (2269:HK) (WXXWY)Morgan Stanley analyst Sean Wu reiterated an Overweight rating and HK$32.00 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).
UBS
$2.12
Hold
-37.42%
Downside
Reiterated
06/12/24
UBS Reiterates Neutral Rating on Wuxi Biologics (2269:HK) (WXXWY)UBS analyst Chen Chen reiterated a Neutral rating and HK$16.60 price target on Wuxi Biologics (2269:HK) (OTC: WXXWY).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wuxi Biologics (Cayman)

1 Month
xxx
Success Rate
3/6 ratings generated profit
50%
Average Return
+2.03%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +2.03% per trade.
3 Months
xxx
Success Rate
4/6 ratings generated profit
67%
Average Return
+8.62%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +8.62% per trade.
1 Year
Success Rate
4/6 ratings generated profit
67%
Average Return
+37.18%
reiterated a buy rating 3 months ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +37.18% per trade.
2 Years
xxx
Success Rate
4/6 ratings generated profit
67%
Average Return
+45.38%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +45.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WXIBF Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Feb 25
Mar 25
May 25
Strong Buy
2
3
5
12
10
Buy
0
0
0
0
0
Hold
4
2
2
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
5
7
15
13
In the current month, WXIBF has received 10 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. WXIBF average Analyst price target in the past 3 months is 4.07.
Each month's total comprises the sum of three months' worth of ratings.

WXIBF Financial Forecast

WXIBF Earnings Forecast

Next quarter’s earnings estimate for WXIBF is $0.06 with a range of $0.06 to $0.06. The previous quarter’s EPS was $0.03. WXIBF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year WXIBF has Preformed in-line its overall industry.
Next quarter’s earnings estimate for WXIBF is $0.06 with a range of $0.06 to $0.06. The previous quarter’s EPS was $0.03. WXIBF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year WXIBF has Preformed in-line its overall industry.

WXIBF Sales Forecast

Next quarter’s sales forecast for WXIBF is $1.34B with a range of $1.34B to $1.34B. The previous quarter’s sales results were $1.41B. WXIBF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 70.18% of the time in the same period. In the last calendar year WXIBF has Outperformed its overall industry.
Next quarter’s sales forecast for WXIBF is $1.34B with a range of $1.34B to $1.34B. The previous quarter’s sales results were $1.41B. WXIBF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 70.18% of the time in the same period. In the last calendar year WXIBF has Outperformed its overall industry.

WXIBF Stock Forecast FAQ

What is WXIBF’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman) Inc.’s 12-month average price target is 4.07.
    What is WXIBF’s upside potential, based on the analysts’ average price target?
    Wuxi Biologics (Cayman) Inc. has 20.41% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WXIBF a Buy, Sell or Hold?
          Wuxi Biologics (Cayman) Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Wuxi Biologics (Cayman) Inc.’s price target?
            The average price target for Wuxi Biologics (Cayman) Inc. is 4.07. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $5.73 ,the lowest forecast is $2.98. The average price target represents 20.41% Increase from the current price of $3.38.
              What do analysts say about Wuxi Biologics (Cayman) Inc.?
              Wuxi Biologics (Cayman) Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of WXIBF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis